Dr. Ellen Cooper is Professor of Pediatrics at Boston University School of Medicine, and is in the Division of Pediatric Infectious Diseases at Boston Medical Center. She founded and still directs the Pediatric HIV Program which now also includes an Adolescent HIV Initiative. In addition she leads the Transition Program for older adolescents who are transitioning to adult care.
She has published widely on the subject of Pediatric HIV treatment and care. She was a principal investigator of a large US based study designed to answer questions surrounding the perinatal transmission of HIV, and this continues to be one of her special interests. She was one of the original members of the HIV Consensus Committee, whose purpose was to establish guidelines for the diagnosis and treatment of HIV infected infants in the US, and her expertise led her to focus also on treatment and care in a number of high burden and low resource countries. She has worked in sites in Uganda, Cameroon, South Africa, Zambia, and in Ethiopia.
She was a participant, trainer and advisor to curriculum development and implementation for the MTCT-Plus Programs in Africa, and served as a technical advisor for ICAP, Columbia in their efforts to establish a Center of Excellence for the care of HIV infected children in Zambia. She continues to be an active participant in the NIH sponsored IMPAACT Network.
- University of Cincinnati College of Medicine, MD
- Johns Hopkins University, MA
- Wellesley College, BS
- Published on 3/26/2021
Epstein RL, Penwill N, Clarke DF, Hamilton S, Horbowicz K, Dorfman D, Moses JM, Cooper ER. "Meds-in-Hand" Intervention to Reduce Critical Process Delays in Pediatric Human Immunodeficiency Virus Post-Exposure Prophylaxis. J Pediatric Infect Dis Soc. 2021 Mar 26; 10(2):196-200. PMID: 32347312.
- Published on 2/16/2021
Hale JE, Platt CD, Bonilla FA, Hay BN, Sullivan JL, Johnston AM, Pasternack MS, Hesterberg PE, Meissner HC, Cooper ER, Barmettler S, Farmer JR, Fisher D, Walter JE, Yang NJ, Sahai I, Eaton RB, DeMaria A, Notarangelo LD, Pai SY, Comeau AM. Ten Years of Newborn Screening for Severe Combined Immunodeficiency (SCID) in Massachusetts. J Allergy Clin Immunol Pract. 2021 Feb 16. PMID: 33607339.
- Published on 7/25/2020
Sinha P, Mostaghim A, Bielick CG, McLaughlin A, Hamer DH, Wetzler LM, Bhadelia N, Fagan MA, Linas BP, Assoumou SA, Ieong MH, Lin NH, Cooper ER, Brade KD, White LF, Barlam TF, Sagar M. Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge. Int J Infect Dis. 2020 Oct; 99:28-33. PMID: 32721528.
- Published on 1/1/2018
Haffey M, Bellamy P, McLaud D, O’Brien A, Moloney C, Clarke D, Amo K, Spinale S, Cooper E, Pelton S. Achieving US Public Health metrics in care of youth with HIV. Presented at the HRSA Ryan White and Global HIV/AIDS Program National Meeting, Boston, MA. 2018.
- Published on 1/1/2017
Epstein R, Penwill N, Clarke D, Hamilton S, Moses J, Cooper E. Reducing Delays to Antiretroviral Receipt in Children Prescribed Post Exposure Prophylaxis for HIV. Presented at ID Week, San Diego CA. 2017.
- Published on 1/1/2017
Epstein R, Penwill N, Clarke D, Hamilton S, Horbowicz K, Dorfman D, Moses J, Cooper E. Reducing Delays to Receipt of PEP in the Pediatric Emergency Department: Meds in Hand and a Multidisciplinary Team Approach. Presented at the Quality Improvement and Safety Conference organized at Boston Medical Center and Boston University School of Medicine (winner of patient safety award) Boston, MA. 2017.
- Published on 1/1/2017
Clarke DF, Yildirim I, Cooper ER. Rapid Initiation of Antiretrovirals in Two Newly Diagnosed HIV-infected Infants. Pediatr Infect Dis J. 2017 Jan; 36(1):61-62. PMID: 27749654.
- Published on 4/2/2015
Peluso AM, Harnish BA, Miller NS, Cooper ER, Fujii AM. Effect of young sibling visitation on respiratory syncytial virus activity in a NICU. J Perinatol. 2015 Aug; 35(8):627-30. PMID: 25836315.
- Published on 8/8/2014
Clarke DF, Moloney C, Cooper ER. Iatrogenic Cushing's Syndrome due to pharmacokinetic interaction of intra-ocular corticosteroids and lopinavir/ritonavir in an HIV- infected adolescent: A case report. J AIDS Clin. Res. 2014.
- Published on 7/30/2014
Ojikutu B, Higgins-Biddle M, Greeson D, Phelps BR, Amzel A, Okechukwu E, Kolapo U, Cabral H, Cooper E, Hirschhorn LR. The association between quality of HIV care, loss to follow-up and mortality in pediatric and adolescent patients receiving antiretroviral therapy in Nigeria. PLoS One. 2014; 9(7):e100039. PMID: 25075742.
View 131 more publications: View full profile at BUMC